Covered recipient · General Payments record
TAMYRA Y COMEAUX
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2018–2024
$5,592.20
- Reported across 80 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,881.55 | 36 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $511.62 | 22 |
| Inspire Medical Systems, Inc. | $276.99 | 3 |
| MERZ NORTH AMERICA, INC. | $263.94 | 4 |
| GENZYME CORPORATION | $254.88 | 2 |
| Astellas Pharma Global Development | $154.23 | 1 |
| Amgen Inc. | $149.90 | 1 |
| Novo Nordisk AS | $121.85 | 1 |
| Alexion Pharmaceuticals, Inc. | $116.15 | 1 |
| REVANCE THERAPEUTICS, INC. | $31.99 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.16 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103494524 | CMS |
| ABBVIE INC. | $22.16 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103494526 | CMS |
| ABBVIE INC. | $30.67 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103494528 | CMS |
| ABBVIE INC. | $21.73 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103494530 | CMS |
| ABBVIE INC. | $26.46 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103494532 | CMS |
| ABBVIE INC. | $48.71 | 03/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103494534 | CMS |
| ABBVIE INC. | $59.54 | 03/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103494536 | CMS |
| ABBVIE INC. | $26.21 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103494538 | CMS |
| ABBVIE INC. | $4.23 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103494540 | CMS |
| ABBVIE INC. | $16.92 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103494542 | CMS |
| ABBVIE INC. | $26.59 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103494544 | CMS |
| ABBVIE INC. | $21.99 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103494546 | CMS |
| ABBVIE INC. | $29.22 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103494548 | CMS |
| ABBVIE INC. | $32.61 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103494550 | CMS |
| ABBVIE INC. | $15.14 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103494552 | CMS |
| ABBVIE INC. | $19.13 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103494554 | CMS |
| ABBVIE INC. | $24.00 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103494556 | CMS |
| ABBVIE INC. | $15.74 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103494558 | CMS |
| ABBVIE INC. | $6.45 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103494560 | CMS |
| ABBVIE INC. | $21.81 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103494562 | CMS |
| ABBVIE INC. | $16.03 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103494564 | CMS |
| ABBVIE INC. | $4.12 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103494566 | CMS |
| Alexion Pharmaceuticals, Inc. | $116.15 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1094016295 | CMS |
| Amgen Inc. | $149.90 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117530396 | CMS |
| Astellas Pharma Global Development | $154.23 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132965283 | CMS |
| GENZYME CORPORATION | $123.92 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139676253 | CMS |
| GENZYME CORPORATION | $130.96 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139676291 | CMS |
| Inspire Medical Systems, Inc. | $113.06 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148048736 | CMS |
| Inspire Medical Systems, Inc. | $127.00 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148048738 | CMS |
| Inspire Medical Systems, Inc. | $36.93 | 09/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148048740 | CMS |
| MERZ NORTH AMERICA, INC. | $92.16 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146375658 | CMS |
| MERZ NORTH AMERICA, INC. | $20.00 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146375654 | CMS |
| MERZ NORTH AMERICA, INC. | $125.96 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146375652 | CMS |
| MERZ NORTH AMERICA, INC. | $25.82 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146375656 | CMS |
| Novo Nordisk Inc | $121.85 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096772627 | CMS |
| REVANCE THERAPEUTICS, INC. | $31.99 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147915125 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.